lung cancer
Conditions
Interventions
PIEB grouping with time interval:Useing BCD to allocate different time intervals
Sponsors
Sun Yat-sen University, Cancer Center
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) Patients who received radical thoracoscopic lung cancer surgery at the Sun Yat-sen University Cancer Center from September 2023 to January 2024; 2) Age > 18 years old, gender is not limited; 3) ASAI-III level; 4) The heart, lungs, liver, and kidney functions are basically normal; 5) The subjects voluntarily participated in the study and signed a written informed consent; 6) The subject has not participated in other clinical studies in the past three months;
Exclusion criteria
Exclusion criteria: 1)Patients with drug allergies used in this study, such as, ropivacaine,lidocaine or sufentanil 2)Surgery involves patients with bilateral or previous history of chest surgery 3)Patients with contraindications to nerve block 4)Patients who have a history of chronic pain or are undergoing pain treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Whether the patient still needs PCEA within 24 hours after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Consumption of local anesthetic drugs;The first time to use PCEA after surgery;Numerical Rating Score for pain;adverse events;ICU admission time;quality of recovery-15 scale (QoR-15) score at 24 hours after surgery; | — |
Countries
China
Contacts
Public ContactLai Renchun
Sun Yat-sen University, Cancer Center
Outcome results
None listed